Connection

James Norris to Tamoxifen

Back to Details
This is a "connection" page, showing publications James Norris has written about Tamoxifen.
James Norris
Connection Strength
0.166
Tamoxifen
  1. Tamoxifen is a candidate first-in-class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells-Unrecognized players in tumorigenesis. Cancer Med. 2020 05; 9(9):3142-3152.
    View in: PubMed
    Score: 0.166
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.